Health Catalyst Q2 Results: Operating results due August 6, 2026 after market close
Health Catalyst, Inc. has announced it will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. A conference call to review the results is scheduled for 5:00 pm ET on the same day, accessible via U.S. dial-in (800-274-8461), international dial-in (203-518-9814), or live audio webcast at https://ir.healthcatalyst.com/. The call replay will remain available for approximately 90 days. The company describes itself as a healthcare intelligence firm backed by $2.8 billion in documented outcomes.
*this image is generated using AI for illustrative purposes only.
Health Catalyst, Inc., a healthcare intelligence company designed to accelerate measurable improvement for health systems, has announced the release date for its second quarter 2026 operating results. The results will be made available on Thursday, August 6, 2026, after market close, with a conference call scheduled for the same day to review the findings.
Conference Call Details
Investors and analysts can participate in the earnings call through multiple access channels. The following table outlines the key details for joining the conference:
| Parameter: | Details |
|---|---|
| Date: | Thursday, August 6, 2026 |
| Time: | 5:00 pm ET |
| U.S. Dial-In: | 800-274-8461 |
| International Dial-In: | 203-518-9814 |
| Conference ID: | HCATQ226 |
| Webcast: | https://ir.healthcatalyst.com/ |
| Replay Availability: | Approximately 90 days post-call |
A live audio webcast will be available online at the investor relations page, and a replay of the call will be accessible via webcast for on-demand listening shortly after the completion of the call at the same web link.
About Health Catalyst
Health Catalyst is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical, and consumer performance. The company is backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, helping health systems move from data to confident, measurable action.
Investor and Media Contacts
Stakeholders seeking additional information may reach out through the following contacts:
- Investor Relations: Stephanie St. Clair, Finance and Investor Relations, SVP — ir@healthcatalyst.com
- Media Contact: Kathryn Larson, Director of Public Relations and Communications — media@healthcatalyst.com
How might Health Catalyst's Q2 2026 results reflect the broader adoption rates of AI-driven healthcare analytics among major health systems?
What specific guidance or strategic initiatives will management highlight regarding the monetization of their $2.8 billion in documented outcomes?
Could the upcoming earnings reveal any shifts in competitive positioning against other healthcare data intelligence platforms?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
